e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Lung cancer: prognostic factors and features of oncogene-driven tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Are serum leptin levels a prognostic factor in advanced lung cancer?
Ceyda Anar (Izmir, Turkey), Ceyda Anar, Derya Deniz, Serhat Erol, Yasemin Ozdogan, Melike Yuksel Yavuz, Ufuk Yilmaz, Huseyin Halilcolar
Source:
International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Session:
Lung cancer: prognostic factors and features of oncogene-driven tumours
Session type:
Thematic Poster Session
Number:
4245
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ceyda Anar (Izmir, Turkey), Ceyda Anar, Derya Deniz, Serhat Erol, Yasemin Ozdogan, Melike Yuksel Yavuz, Ufuk Yilmaz, Huseyin Halilcolar. Are serum leptin levels a prognostic factor in advanced lung cancer?. Eur Respir J 2015; 46: Suppl. 59, 4245
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Serum osteopontin as a prognostic marker in patients with lung cancer
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
The prognostic value of D-dimer in lung carcinoma
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Prognostic factors for survival in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Serum level of interleukin-6 as a prognostic factor in advanced nonsmall-cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 250s
Year: 2003
Locally advanced stage nonsmallcell cancers explode in hyperglisemia: A new prognostic factors?
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Prognostic significance of serum vascular endothelial growth factor and angiopoietin-2 in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Correlation between the simultaneus expression of HER2 and PTEN and the risk of development of metastasis in NSCLC
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
The impact of lung cancer resection surgery on fibrinogen and C-reactive protein and their relationship with patients outcomes: A prospective follow up study
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016
Procalcitonin serum levels in patients with stage IV non-small cell lung cancer in first line of chemotherapy
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology
Source: Eur Respir J 2013; 41: 410-416
Year: 2013
Exploring the neutrophil/lymphocyte and platelet/lymphocyte ratios as biomarkers for lung cancer development
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference?
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Neutrophil to lymphocyte ratio (NLR) as a predictor of poor prognosis in advanced non-small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Neutrophil/lymphocyte ratio as a prognostic marker for curative-intent surgery in non-small cell lung cancer
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept